Pharma & healthcare
The pharmaceutical and healthcare industry is experiencing challenges from complex regulations to spending constraints, but also significant opportunity with the development of medicine and technology in the diagnosis and treatment of diseases.
We provide support to the largest multinational pharmaceutical and healthcare groups, as well as start-ups, universities and emerging biotechnology ventures.
Our lawyers’ partner with our clients at every level of their businesses to help them achieve their goals from corporate transactions and regulatory to immigration law and HR employment matters. We also handle large-scale litigation, tribunals and industrial relations both at a national and global level.
As a founding member of TAGLaw, our international legal network ensures that we have a ready resource of expertise to advise on cross-border work.
“The firm is highly professional, but also maintains personality and humanity in its approach to the law and clients.”
Chambers and Partners
Read, listen and watch our latest insights
- 05 September 2017
How to avoid construction payment disputes
Payment disputes continue to be one of the most common problems in the construction industry, and we have published numerous articles on the key court decisions that affect the interpretation of payment provisions
- 05 September 2017
Payment in Construction Contracts – What’s new?
Payment provisions are an industry “hot topic” and the wave of litigation since the 2009 amendments to the Construction Act remains relevant. If you would like a reminder of the principles to follow when applying for or making payment, then see our previous articles here and here.
- 04 September 2017
Tribunal fees: should you prepare for a deluge of claims and what happens next?
It has been a tumultuous few years for the Conservative party and the recent Supreme Court ruling has added to the party’s list of woes. The government will now have to repay £32m to parties following the Court’s unanimous decision that the tribunal fee regime was unlawful.
- 31 August 2017
- Corporate and M&A
Directors’ & Officers’ Liability Insurance
We are often asked by directors (both exec and non-exec) of clients about whether their company should have D & O liability insurance in place, and what it does and does not cover.
- 17 August 2017
The pitfalls of a sole director company
If the director shareholder of a small company, were to unexpectedly die the company may be in a vacuum.
“Invariably extremely knowledgeable, efficient, well-prepared and delightful to work with. Cannot rate them too highly.”